Improving clinical trial efficiency: thinking outside the box
Indeed, the history of anti-obesity medications has been marked by several failures due to serious adverse events, such as suicidality, observed only after their usage had become extensive 221,234 a well-known example being the one that led to the withdrawal of the endocannabinoid inverse agonist, rimonabant 235
This included Israel Simon Kleiner and Samuel Meltzer, two American physiologists, based at the Rockefeller University in New York who in 1915 demonstrated with animal experiments the power of intravenously administered pancreatic extracts in lowering blood sugar
erased 74% of gross sales, including rebates for managed care plans, Medicare, Medicaid and the 340B Drug Pricing Program
These providers make clinical decisions based on the health information patients provide
GLP-1 Receptor Agonists: The New Wave in Diabetes Management In the realm of diabetes management, GLP-1 (Glucagon-Like Peptide-1) receptor agonists have emerged as a significant breakthrough, garnering considerable attention among healthcare professionals and patients alike
